Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

[18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice.

Wong-Sefidan I, Byrtek M, Zhou X, Friedberg JW, Flowers CR, Zelenetz AD, Dawson KL, Reid E.

Leuk Lymphoma. 2017 Apr;58(4):809-815. doi: 10.1080/10428194.2016.1213824.

PMID:
27562750
2.

The effectiveness of parallel gamma-interferon testing in New Zealand's bovine tuberculosis eradication programme.

Sinclair JA, Dawson KL, Buddle BM.

Prev Vet Med. 2016 May 1;127:94-9. doi: 10.1016/j.prevetmed.2016.03.020.

PMID:
27094146
3.
4.

Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†.

Casulo C, Day B, Dawson KL, Zhou X, Flowers CR, Farber CM, Hainsworth JD, Cerhan JR, Link BK, Zelenetz AD, Friedberg JW.

Ann Oncol. 2015 Nov;26(11):2311-7. doi: 10.1093/annonc/mdv375.

5.

Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study.

Casulo C, Byrtek M, Dawson KL, Zhou X, Farber CM, Flowers CR, Hainsworth JD, Maurer MJ, Cerhan JR, Link BK, Zelenetz AD, Friedberg JW.

J Clin Oncol. 2015 Aug 10;33(23):2516-22. doi: 10.1200/JCO.2014.59.7534. Erratum in: J Clin Oncol. 2016 Apr 20;34(12):1430.

6.

Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS).

Wagner-Johnston ND, Link BK, Byrtek M, Dawson KL, Hainsworth J, Flowers CR, Friedberg JW, Bartlett NL.

Blood. 2015 Aug 13;126(7):851-7. doi: 10.1182/blood-2015-01-621375.

7.

Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial.

Aiello LP, Ayala AR, Antoszyk AN, Arnold-Bush B, Baker C, Bressler NM, Elman MJ, Glassman AR, Jampol LM, Melia M, Nielsen J, Wolpert HA; Diabetic Retinopathy Clinical Research Network..

JAMA Ophthalmol. 2015 Aug;133(8):888-96. doi: 10.1001/jamaophthalmol.2015.1312.

8.

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.

Diabetic Retinopathy Clinical Research Network., Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW.

N Engl J Med. 2015 Mar 26;372(13):1193-203. doi: 10.1056/NEJMoa1414264.

9.

Topical nepafenec in eyes with noncentral diabetic macular edema.

Friedman SM, Almukhtar TH, Baker CW, Glassman AR, Elman MJ, Bressler NM, Maker MP, Jampol LM, Melia M; Diabetic Retinopathy Clinical Research Network..

Retina. 2015 May;35(5):944-56. doi: 10.1097/IAE.0000000000000403.

10.

Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim.

Kuter DJ, Macahilig C, Grotzinger KM, Poston SA, Wang PF, Dawson KL, Ward M.

Int J Hematol. 2015 Mar;101(3):255-63. doi: 10.1007/s12185-014-1731-7.

PMID:
25586660
11.

Patients with cirrhosis show a relative increase in thrombin generation that is correlated with lower antithrombin levels.

Chandler WL, Dawson KL, Ruegger MC, Teruya M, Liebl PH, Monsour HP.

Blood Coagul Fibrinolysis. 2014 Nov 14. [Epub ahead of print]

PMID:
25402190
12.

Comparison of the effectiveness of frontline chemoimmunotherapy regimens for follicular lymphoma used in the United States.

Nastoupil LJ, Sinha R, Byrtek M, Ziemiecki R, Taylor M, Friedberg JW, Koff JL, Link BK, Cerhan JR, Dawson KL, Flowers CR.

Leuk Lymphoma. 2015 May;56(5):1295-302. doi: 10.3109/10428194.2014.953144.

PMID:
25263322
13.

Recurrent bovine tuberculosis in New Zealand cattle and deer herds, 2006-2010.

Dawson KL, Stevenson MA, Sinclair JA, Bosson MA.

Epidemiol Infect. 2014 Oct;142(10):2065-74. doi: 10.1017/S0950268814000910.

PMID:
24759569
14.

Aminoacyl-tRNA synthetases as drug targets in eukaryotic parasites.

Pham JS, Dawson KL, Jackson KE, Lim EE, Pasaje CF, Turner KE, Ralph SA.

Int J Parasitol Drugs Drug Resist. 2013 Nov 11;4(1):1-13. doi: 10.1016/j.ijpddr.2013.10.001. Review.

15.

A phase 1 trial of eltrombopag in patients undergoing stem cell transplantation after total body irradiation.

Liesveld JL, Phillips GL 2nd, Becker M, Constine LS, Friedberg J, Andolina JR, Milner LA, DeBolt J, Smudzin T, Hyrien O, Erickson-Miller CL, Johnson BM, Dawson KL, Chen Y.

Biol Blood Marrow Transplant. 2013 Dec;19(12):1745-52. doi: 10.1016/j.bbmt.2013.10.002.

16.

Clostridium difficile infection after lung transplantation: are we really doing everything possible?

Dawson KL, Mooney ML.

J Heart Lung Transplant. 2013 Oct;32(10):1002-4. doi: 10.1016/j.healun.2013.07.010. No abstract available.

PMID:
23953917
17.

Effect of hypogammaglobulinemia on the incidence of community-acquired respiratory viral infections after lung transplantation.

Noell BC, Dawson KL, Seethamraju H.

Transplant Proc. 2013 Jul-Aug;45(6):2371-4. doi: 10.1016/j.transproceed.2012.11.010.

PMID:
23747186
18.

Treatment of hyperacute antibody-mediated lung allograft rejection with eculizumab.

Dawson KL, Parulekar A, Seethamraju H.

J Heart Lung Transplant. 2012 Dec;31(12):1325-6. doi: 10.1016/j.healun.2012.09.016. No abstract available.

PMID:
23063321
19.

A new epoprostenol formulation for the treatment of pulmonary arterial hypertension.

Fuentes A, Coralic A, Dawson KL.

Am J Health Syst Pharm. 2012 Aug 15;69(16):1389-93. doi: 10.2146/ajhp110687. Review.

PMID:
22855104
20.

Transmission of Mycobacterium orygis (M. tuberculosis complex species) from a tuberculosis patient to a dairy cow in New Zealand.

Dawson KL, Bell A, Kawakami RP, Coley K, Yates G, Collins DM.

J Clin Microbiol. 2012 Sep;50(9):3136-8. doi: 10.1128/JCM.01652-12.

Items per page

Supplemental Content

Loading ...
Support Center